Investor Type | Firm |
Type of Fund | Other |
Industries | BioTech • HealthTech (& Fitness) • Blockchain (& Cryptos) • Food & Beverage • Impact • Medical Devices (& Hospital Services) • Robotics • Healthcare (& Wellness) • Consumer • Pharmaceutical (& Medicine) • Woman Focused |
Stages | Seed, Series A, Series B, Pre-seed |
Investing | United States |
Investment Range | $250,000 - $10,000,000 |
Investment Sweet Spot | $2,000,000 |
Assets Under Management | $26,500,000 |
Genoa Ventures is a venture capital firm with a clear focus on the intersection of biology and technology. They are based in San Francisco, California, and dedicate their resources to accelerating innovation and transforming industries through strategic investments. With a minimum investment threshold of $250,000 and a maximum investment cap of $10,000,000, their sweet spot for funding typically lies around $2,000,000. Their investment specialties include Seed, Series A, Series B, and Pre-seed funding stages, demonstrating their commitment to supporting companies from their inception through their early growth phases. Genoa Ventures operates with $26,500,000 in assets under management and has an investment thesis that revolves around the convergence of biology and technology to create significant advancements across various sectors. They actively invest in BioTech, HealthTech (and Fitness), Blockchain (and Cryptos), Food & Beverage, Impact, Medical Devices (and Hospital Services), Robotics, Healthcare (and Wellness), Consumer, Pharmaceutical (and Medicine), and Woman Focused industries. They recognize the vast potential that lies in the fusion of scientific innovation and technological breakthroughs, and their goal is to empower the next generation of category-defying companies that aim to build a healthier, cleaner, and more productive world. Genoa Ventures leverages scientific excellence to inform investment decisions, ensuring deep domain expertise guides their support for portfolio companies.